Skip to main content
Nath Biogene India Ltd. logo

Nath Biogene India Ltd. — Investor Relations & Filings

Ticker · NATHBIOGEN ISIN · INE448G01010 BSE.NS Agriculture, forestry and fishing
Open in API
Filings indexed 450 across all filing types
Latest filing 2025-04-29 Investor Presentation
Country IN India
Listing BSE.NS NATHBIOGEN

About Nath Biogene India Ltd.

https://www.nathbiogenes.com

Nath Biogene India Ltd. specializes in the research, development, production, and marketing of high-quality hybrid seeds. The company maintains a diverse product portfolio encompassing field crops such as cotton, paddy, maize, jowar, and bajra, alongside a wide range of vegetable seeds including tomato, okra, and chili. With a strong emphasis on biotechnological innovation and plant breeding, the organization focuses on developing high-yielding, pest-resistant, and climate-resilient seed varieties to enhance agricultural productivity. Its operations are supported by extensive research and development facilities and a robust distribution network that ensures the delivery of advanced genetic materials to farming communities. The company leverages its technical expertise to provide integrated solutions aimed at improving crop quality and farmer profitability through sustainable agricultural practices.

Recent filings

Filing Released Lang Actions
Updates
Investor Presentation Classification · 95% confidence The document is a detailed presentation dated 29th April 2025, titled 'Investor Presentation – Q4 & FY25' and includes comprehensive financial data such as revenue, EBITDA, profit margins, segmental revenue, income statements, balance sheets, and historical financials. It is explicitly described as a presentation on audited financial results for the period ended 31st March 2025. The content includes forward-looking statements, business strategy, operational highlights, and detailed financial performance metrics typical of an investor presentation. The document length is over 10,000 characters, indicating it is the full presentation rather than a brief announcement. Therefore, the document fits the category of an Investor Presentation (IP) rather than an Earnings Release or Annual Report, as it focuses on presenting financial results and business strategy to investors in a presentation format.
2025-04-29 English
Outcome of Board Meeting
Regulatory Filings
2025-04-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is a notification about an upcoming earnings conference call scheduled for April 30, 2025. It includes details such as the date, time, participants, and dial-in information. There is no actual financial data or results presented in this document. It is an announcement informing stakeholders about the call rather than the transcript or report of the call itself. Therefore, this document fits the category of a Call Transcript announcement or invitation, but since it is only an announcement of the call and not the transcript, it is best classified as a Call Transcript (CT) type document, as per the definitions, this is the closest match. Confidence is high due to clear keywords like 'Earning Conference Call' and detailed call logistics.
2025-04-24 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-04-21 English
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve the audited financial results for the quarter and year ended 31 March 2025, along with other agenda items such as dividend recommendation and AGM date. It is an intimation to stock exchanges as per SEBI regulations about the upcoming board meeting. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is a short notice informing about the meeting where the results will be approved and announced. Therefore, it is an announcement related to board meeting activities but not a management or board information announcement about changes in personnel. It is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about an upcoming event and not the actual report or detailed financial disclosure.
2025-04-21 English
Issue of Duplicate Share Certificate
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issuance of a duplicate share certificate due to the original being lost. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 39(3), which pertains to share certificate management. The content is about a specific share certificate replacement and does not contain financial statements, earnings data, or management discussion. It is not an announcement of a report, nor a report itself. This type of document fits the category of Share Issue/Capital Change (SHA) because it deals with changes in share certificates, which is a capital-related matter.
2025-04-21 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.